Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Colorado, Denver
BPGbio
iTeos Therapeutics
Radboud University Medical Center
Peking University
Celldex Therapeutics
University of Chicago
AbbVie
H. Lee Moffitt Cancer Center and Research Institute
AbbVie
Yale University
Aduro Biotech, Inc.
University of Maryland, Baltimore
Abramson Cancer Center at Penn Medicine
Oncolytics Biotech
Daiichi Sankyo
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Utah
Swedish Orphan Biovitrum
St. Jude Children's Research Hospital
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
GOG Foundation
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Centro Hospitalar Nordeste
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center